ACS + 2P: 2 Flashcards
ED: STEMI
-HEPARIN IV
+/-METOPROLOL IV
MONA:
1. Morphine
2. Oxygen
3. NTG SL/IV
4. Aspirin/Clopidogrel
Morphine: STEMI
1-5 mg IV Q5-30min
AVOID in lethargy, low BP, bradycardia
Morphine + Clopidogrel = DDI caution
Oxygen: STEMI
2-4 lpm if O2 < 90, HF, dyspnea
NTG: STEMI
0.4 mg Q5min x3doses
IV: 10 mcg/min if pain not controlled
Don’t use if BP < 90 or < 30 below baseline
Aspirin: STEMI
325 mg asap for STEMI
Heparin: STEMI ED
If fibrinolysis:
-60 u/kg (max 4k)
-12 u/kg (max 1k)
If primary PCI/med man:
-60 u/kg (max 5k)
-12 u/kg (max 1k)
BB: STEMI
Metoprolol Tartrate 5 mg IV up to x3d
Reperfusion Therapy: ED for STEMI
– Door-2-Balloon: 90 minutes (primary PCI)
– Door-2-Needle: 30 minutes (thrombolysis)
Characteristics of patients w/ higher risk of ICH with Fibrinolysis
-Female
-75+
-Cerebral vascular disease
-HTN
Tenecteplase Dosing in ED for STEMI
- < 60 kg: 30 mg
- 60-69 kg: 35 mg
- 70-79 kg: 40 mg
- 80-89 kg: 45 mg
- > 90 kg: 50 mg
STEMI - Primary PCI: Cath Lab: Antithrombotic Strategies
- Continue heparin from ED as monotherapy
- Continue heparin and add cangrelor
- Stop heparin and start bivalirudin monotherapy
- Stop heparin and start bivalirudin + cangrelor
Clopidogrel: STEMI
Give in Cath lab if not given already in ED as part of early tx
Genetic variability with CYP2C19*2 (avoid omeprazole esomeprazole, can use pantoprazole/HSRA)
Dose: 300 mg LD (for fibrinolysis), 75 mg QD MD
Prasugrel: STEMI
CI in TIA/STROKE history
LD 60 mg, 10 mg QD MD (< 60 kg: 5 mg)
Only indicated in ACS to be managed with PCI
Ticagrelor: STEMI
Indicated for ACS (PCI or non-invasive medical management)
LD 180 mg, 90 mg BID MD
Dyspnea AE (caution asthma/copd)
Can’t use in ICH patients
ICU/Ward: Later TX for 2ndary Prevention for STEMI
-ACEI (within 24 hr for AMI/STEMI/<40LVEF)